日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Plasma gelsolin levels are associated with diabetes, sex, race, and poverty

血浆凝溶胶蛋白水平与糖尿病、性别、种族和贫困有关。

Noren Hooten, Nicole; Mode, Nicolle A; Kowalik, Edward; Omoniyi, Victor; Zonderman, Alan B; Ezike, Ngozi; DiNubile, Mark J; Levinson, Susan L; Evans, Michele K

Low HDL-c levels at admission are associated with greater severity and worse clinical outcomes in patients with COVID-19 disease

入院时低密度脂蛋白胆固醇(HDL-c)水平与新冠肺炎患者病情更严重和临床预后更差相关。

Parra, Sandra; Saballs, Mireia; DiNubile, Mark; Feliu, Mireia; Iftimie, Simona; Revuelta, Laia; Pavón, Raul; Àvila, Alba; Levinson, Susan; Castro, Antoni

Blood-Borne Microparticles Are an Inflammatory Stimulus in Type 2 Diabetes Mellitus

血液中的微粒是 2 型糖尿病的炎症刺激物

Stephen R Thom, Veena M Bhopale, Awadhesh K Arya, Deepa Ruhela, Abid R Bhat, Nandita Mitra, Ole Hoffstad, D Scot Malay, Ziad K Mirza, John C Lantis, Hadar A Lev-Tov, Robert S Kirsner, Ru-Ching Hsia, Susan L Levinson, Mark J DiNubile, David J Margolis

Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia

用于治疗2019冠状病毒病重症肺炎的辅助性重组人血浆凝溶胶蛋白

DiNubile, Mark J; Parra, Sandra; Salomó, Antoni Castro; Levinson, Susan L

Association of plasma gelsolin with frailty phenotype and mortality among octogenarian community-dwelling men: a cohort study

血浆凝溶胶蛋白与八旬社区居住男性衰弱表型和死亡率的关联:一项队列研究

Strandberg, Timo E; Levinson, Susan L; DiNubile, Mark J; Jyväkorpi, Satu; Kivimäki, Mika

An immune-based biomarker signature is associated with mortality in COVID-19 patients

一种基于免疫的生物标志物特征与新冠肺炎患者的死亡率相关

Abers, Michael S; Delmonte, Ottavia M; Ricotta, Emily E; Fintzi, Jonathan; Fink, Danielle L; de Jesus, Adriana A Almeida; Zarember, Kol A; Alehashemi, Sara; Oikonomou, Vasileios; Desai, Jigar V; Canna, Scott W; Shakoory, Bita; Dobbs, Kerry; Imberti, Luisa; Sottini, Alessandra; Quiros-Roldan, Eugenia; Castelli, Francesco; Rossi, Camillo; Brugnoni, Duilio; Biondi, Andrea; Bettini, Laura Rachele; D'Angio', Mariella; Bonfanti, Paolo; Castagnoli, Riccardo; Montagna, Daniela; Licari, Amelia; Marseglia, Gian Luigi; Gliniewicz, Emily F; Shaw, Elana; Kahle, Dana E; Rastegar, Andre T; Stack, Michael; Myint-Hpu, Katherine; Levinson, Susan L; DiNubile, Mark J; Chertow, Daniel W; Burbelo, Peter D; Cohen, Jeffrey I; Calvo, Katherine R; Tsang, John S; Su, Helen C; Gallin, John I; Kuhns, Douglas B; Goldbach-Mansky, Raphaela; Lionakis, Michail S; Notarangelo, Luigi D

Low Plasma Gelsolin Concentrations in Chronic Granulomatous Disease

慢性肉芽肿病患者血浆凝溶胶蛋白浓度低

Audley, John; Gliniewicz, Emily F; Zarember, Kol A; Hong, Hanna S; Wald, Gal; Kuhns, Douglas B; Kang, Elizabeth; Malech, Harry L; Suffredini, Anthony F; Noveck, Robert J; Dinubile, Mark J; Levinson, Susan L; Stossel, Thomas P; Gallin, John I

Recombinant human plasma gelsolin (rhu-pGSN) in a patient hospitalized with critical COVID-19 pneumonia

重组人血浆凝溶胶蛋白(rhu-pGSN)用于治疗一名因重症 COVID-19 肺炎住院的患者

Catteeuw, Julie V; DiNubile, Mark J

Safety and Pharmacokinetics of Recombinant Human Plasma Gelsolin in Patients Hospitalized for Nonsevere Community-Acquired Pneumonia.

重组人血浆凝溶胶蛋白在非重症社区获得性肺炎住院患者中的安全性和药代动力学

Tannous Abla, Levinson Susan L, Bolognese James, Opal Steven M, DiNubile Mark J

Low Admission Plasma Gelsolin Concentrations Identify Community-acquired Pneumonia Patients at High Risk for Severe Outcomes

入院时血浆凝溶胶蛋白浓度低可识别社区获得性肺炎中发生严重后果的高风险患者

Self, Wesley H; Wunderink, Richard G; DiNubile, Mark J; Stossel, Thomas P; Levinson, Susan L; Williams, Derek J; Anderson, Evan J; Bramley, Anna M; Jain, Seema; Edwards, Kathryn M; Grijalva, Carlos G